Qual Supremo for Ziment

New York-based healthcare and pharma researcher Ziment has appointed Ms. Basya Gale, Ph.D. as its Worldwide Chief Qualitative Officer.

Gale has more than 25 years of experience in pharmaceutical marketing research on both client and supplier sides at companies including IMS Health Consulting, Bristol-Myers Squibb, Johnson & Johnson, AstraZeneca, and Rhone-Poulenc Rorer. Her therapeutic expertise reflects her business experience and ranges across areas such as, cardiovascular, diabetes, urology, infectious disease, dermatology, hematology, musculoskeletal, respiratory, CNS, bone metabolism, AIDS and oncology.

Lynnette Cooke, CEO of The Ziment Group's custom research division, says Gale is 'the ideal person' to lead Ziment's Qualitative Services division. 'She is a leader in our industry and her vision will help to shape new offerings that will help move our clients' businesses forward, no matter where they are doing business in the world.' Gale herself comments: 'I believe that qualitative marketing research has a more important role than ever in helping our healthcare and pharmaceutical clients understand and impact their world.'

The Ziment Group, the healthcare company of Kantar within WPP, consists of full service consultancy Ziment, physician panel WebSurveyResearch; syndicated tracking division imap Research; and Consumer Health Sciences, which conducts the National Health and Wellness Survey (nhwsurvey.com) . It is online at www.zimentgroup.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Ziment Group
• All news